Skip to content

Efficacy of a Mobile Phone App for Depression and Anxiety in College Students

Efficacy of a Mobile Phone Application for Early Intervention of Depression and Anxiety in Young College Students

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06628830
Acronym
VamosJuntxs
Enrollment
200
Registered
2024-10-08
Start date
2024-05-23
Completion date
2025-08-30
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Symptoms, Depressive Symptoms

Keywords

digital intervention, depression, anxiety, app-based Intervention, university students, well-being, college students, mobile phone app

Brief summary

The goal of this clinical trial is to evaluate the efficacy of a mobile phone application for the early intervention of depression and anxiety among young university students in Chile. The main question it aims to answer is: \- Can a mobile app reduce depressive and anxious symptomatology in college students? Researchers will compare the intervention arm (mobile app users) to the control group (receives psychoeducational material and mental health care resources) to see if the app leads to significant improvements in depressive and anxious symptoms and well-being. Participants will: * Be randomly assigned to either the intervention or control group. * Use the mobile application, which includes psychoeducational materials, cognitive-behavioral therapy modules, and periodic personalized feedback. * Complete assessments at baseline, post-intervention, and 3 and 6 months after randomization using online tools such as the PHQ-9 for depressive symptoms and the GAD-7 for anxious symptoms.

Interventions

DEVICEVamosJuntxs App

Psychoeducational materials (videos, information and interactive exercises) about depression, anxiety and social support Skills training through information and activities based on the principles of cognitive behavioral therapy (cognitive restructuring, behavioral activation, emotional regulation, problem solving and exposure)

OTHERWeb Conciencia Saludable

mental health psychoeducational campaign (https://concienciasaludable.uchile.cl/)

Sponsors

University of Talca
CollaboratorOTHER
Universidad de los Andes, Chile
CollaboratorOTHER
Universidad Austral de Chile
CollaboratorOTHER
Millennium Nucleus to Improve the Mental Health of Adolescents and Youths (Imhay) NCS2021_081
CollaboratorUNKNOWN
University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

* PHQ-9 and GAD-7 score between 5 and 14 points * Have a stable internet connection * To provide informed consent

Exclusion criteria

* High risk of suicide according to C-SSRS * Currently undergoing psychological, psychiatric and/or psychopharmacological treatment * Bipolar disorder, psychotic disorder or substance use disorder assessed with the respective modules of the MINI interview.

Design outcomes

Primary

MeasureTime frameDescription
Depression symptoms6-weeks post-randomizationPHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
Anxiety symptoms6-weeks post-randomizationGAD-7, total score varies between 0 and 21, higher values represent a worse outcome

Secondary

MeasureTime frameDescription
Well-being6-weeks post-randomizationThe Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
User Satisfaction6-weeks post-randomizationAd-hoc satisfaction questionnaire for the intervention group, total score varies between 7 and 28, higher values represent a better outcome and an overall index with values ranging from 1 to 10
Depression symptoms3-months post-randomizationPHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
Anxiety symptoms3-months post-randomizationGAD-7, total score varies between 0 and 21, higher values represent a worse outcome

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026